AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 80 filers reported holding AGILE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,000 | -60.0% | 10,200 | +2.0% | 0.00% | – |
| Q4 2021 | $5,000 | -50.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -23.1% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $13,000 | -38.1% | 10,000 | 0.0% | 0.00% | – |
| Q1 2021 | $21,000 | -73.1% | 10,000 | -63.0% | 0.00% | – |
| Q4 2020 | $78,000 | -4.9% | 27,041 | 0.0% | 0.00% | – |
| Q3 2020 | $82,000 | +9.3% | 27,041 | 0.0% | 0.00% | – |
| Q2 2020 | $75,000 | +50.0% | 27,041 | 0.0% | 0.00% | – |
| Q1 2020 | $50,000 | +100.0% | 27,041 | +170.4% | 0.00% | – |
| Q4 2019 | $25,000 | +108.3% | 10,000 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | -20.0% | 10,000 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | 0.0% | 10,000 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | +150.0% | 10,000 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | +50.0% | 10,000 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 10,000 | +19900.0% | 0.00% | – |
| Q4 2014 | $0 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 4,668,763 | $43,278,000 | 14.12% |
| Aisling Capital LLC | 2,983,797 | $27,660,000 | 3.62% |
| INVESTOR AB | 3,510,189 | $32,539,000 | 2.91% |
| Foresite Capital Management II, LLC | 459,266 | $4,257,000 | 2.52% |
| RA Capital Management | 1,458,792 | $13,523,000 | 1.34% |
| Sio Capital Management, LLC | 203,732 | $1,889,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 80,959 | $750,000 | 0.63% |
| Pinnacle Wealth Management Advisory Group, LLC | 49,623 | $460,000 | 0.41% |
| CAXTON CORP | 26,736 | $248,000 | 0.30% |
| Cormorant Asset Management, LP | 182,053 | $1,688,000 | 0.26% |